Dr. Joel Scherer, MD – North Waltham, MA
Ava Hudson
Updated on July 05, 2026
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placeb...
David W Dodick, Peter J Goadsby, Egilius L H Spierings, Joel C Scherer, Steven P Sweeney, David S Grayzel, Lancet Neurology, 8/11/2014
